Cargando…
Correction to: The epidemiologic impact and cost-effectiveness of new tuberculosis vaccines on multidrug-resistant tuberculosis in India and China
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8887015/ https://www.ncbi.nlm.nih.gov/pubmed/35227254 http://dx.doi.org/10.1186/s12916-022-02306-3 |
| _version_ | 1784660807083098112 |
|---|---|
| author | Weerasuriya, Chathika K. Harris, Rebecca C. McQuaid, C. Finn Bozzani, Fiammetta Ruan, Yunzhou Li, Renzhong Li, Tao Rade, Kirankumar Rao, Raghuram Ginsberg, Ann M. Gomez, Gabriela B. White, Richard G. |
| author_facet | Weerasuriya, Chathika K. Harris, Rebecca C. McQuaid, C. Finn Bozzani, Fiammetta Ruan, Yunzhou Li, Renzhong Li, Tao Rade, Kirankumar Rao, Raghuram Ginsberg, Ann M. Gomez, Gabriela B. White, Richard G. |
| author_sort | Weerasuriya, Chathika K. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8887015 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-88870152022-03-17 Correction to: The epidemiologic impact and cost-effectiveness of new tuberculosis vaccines on multidrug-resistant tuberculosis in India and China Weerasuriya, Chathika K. Harris, Rebecca C. McQuaid, C. Finn Bozzani, Fiammetta Ruan, Yunzhou Li, Renzhong Li, Tao Rade, Kirankumar Rao, Raghuram Ginsberg, Ann M. Gomez, Gabriela B. White, Richard G. BMC Med Correction BioMed Central 2022-03-01 /pmc/articles/PMC8887015/ /pubmed/35227254 http://dx.doi.org/10.1186/s12916-022-02306-3 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| spellingShingle | Correction Weerasuriya, Chathika K. Harris, Rebecca C. McQuaid, C. Finn Bozzani, Fiammetta Ruan, Yunzhou Li, Renzhong Li, Tao Rade, Kirankumar Rao, Raghuram Ginsberg, Ann M. Gomez, Gabriela B. White, Richard G. Correction to: The epidemiologic impact and cost-effectiveness of new tuberculosis vaccines on multidrug-resistant tuberculosis in India and China |
| title | Correction to: The epidemiologic impact and cost-effectiveness of new tuberculosis vaccines on multidrug-resistant tuberculosis in India and China |
| title_full | Correction to: The epidemiologic impact and cost-effectiveness of new tuberculosis vaccines on multidrug-resistant tuberculosis in India and China |
| title_fullStr | Correction to: The epidemiologic impact and cost-effectiveness of new tuberculosis vaccines on multidrug-resistant tuberculosis in India and China |
| title_full_unstemmed | Correction to: The epidemiologic impact and cost-effectiveness of new tuberculosis vaccines on multidrug-resistant tuberculosis in India and China |
| title_short | Correction to: The epidemiologic impact and cost-effectiveness of new tuberculosis vaccines on multidrug-resistant tuberculosis in India and China |
| title_sort | correction to: the epidemiologic impact and cost-effectiveness of new tuberculosis vaccines on multidrug-resistant tuberculosis in india and china |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8887015/ https://www.ncbi.nlm.nih.gov/pubmed/35227254 http://dx.doi.org/10.1186/s12916-022-02306-3 |
| work_keys_str_mv | AT weerasuriyachathikak correctiontotheepidemiologicimpactandcosteffectivenessofnewtuberculosisvaccinesonmultidrugresistanttuberculosisinindiaandchina AT harrisrebeccac correctiontotheepidemiologicimpactandcosteffectivenessofnewtuberculosisvaccinesonmultidrugresistanttuberculosisinindiaandchina AT mcquaidcfinn correctiontotheepidemiologicimpactandcosteffectivenessofnewtuberculosisvaccinesonmultidrugresistanttuberculosisinindiaandchina AT bozzanifiammetta correctiontotheepidemiologicimpactandcosteffectivenessofnewtuberculosisvaccinesonmultidrugresistanttuberculosisinindiaandchina AT ruanyunzhou correctiontotheepidemiologicimpactandcosteffectivenessofnewtuberculosisvaccinesonmultidrugresistanttuberculosisinindiaandchina AT lirenzhong correctiontotheepidemiologicimpactandcosteffectivenessofnewtuberculosisvaccinesonmultidrugresistanttuberculosisinindiaandchina AT litao correctiontotheepidemiologicimpactandcosteffectivenessofnewtuberculosisvaccinesonmultidrugresistanttuberculosisinindiaandchina AT radekirankumar correctiontotheepidemiologicimpactandcosteffectivenessofnewtuberculosisvaccinesonmultidrugresistanttuberculosisinindiaandchina AT raoraghuram correctiontotheepidemiologicimpactandcosteffectivenessofnewtuberculosisvaccinesonmultidrugresistanttuberculosisinindiaandchina AT ginsbergannm correctiontotheepidemiologicimpactandcosteffectivenessofnewtuberculosisvaccinesonmultidrugresistanttuberculosisinindiaandchina AT gomezgabrielab correctiontotheepidemiologicimpactandcosteffectivenessofnewtuberculosisvaccinesonmultidrugresistanttuberculosisinindiaandchina AT whiterichardg correctiontotheepidemiologicimpactandcosteffectivenessofnewtuberculosisvaccinesonmultidrugresistanttuberculosisinindiaandchina |